Blog - Page 4174 of 5631

WednesdayMar 25, 2009 6:09 am

ADVENTRX Pharmaceuticals, Inc. (ANX) Grants Exclusive Rights to Lead Product Candidate

ADVENTRX Pharmaceuticals, Inc. announced that it has granted Shin Poong Pharmaceutical Co., Ltd. (SEO: 019170.KS) the exclusive rights to make, use and sell ANX-514 (docetaxel emulsion), one of its two lead product candidates, in South Korea. In exchange, ADVENTRX will receive an upfront cash payment of $300,000, up to approx. $2 million in regulatory and commercial milestones, and royalties on net sales of licensed products. "Shin Poong is well-positioned to successfully develop and commercialize ANX-514 in South Korea," commented Brian M. Culley, Chief Business Officer of ADVENTRX. "Established in 1962, Shin Poong has grown to more than 1,500 employees. They…

WednesdayMar 25, 2009 6:00 am

China 3C Group (CHCG.OB) Announces Financial Results for Fourth Quarter and Full Year 2008

China 3C Group, a retailer and wholesale distributor of consumer and business products in China, reported its financial results for the fourth quarter and full year of 2008. Net sales for the fourth quarter of 2008 totaled $84.9 million, a 22.9% increase compared to $69.1 million for the same period of the prior year. The company's retail business accounted for approximately 68% of sales while the wholesale business generated approximately 32% of sales. Net sales for last year increased 13% to $310.6 million, versus $276.0 million for 2007. General and administrative expenses for the year totaled $14.1 million, or approximately…

WednesdayMar 25, 2009 5:49 am

Human Genome Sciences, Inc. (HGSI) and Morphotek(R), Inc. Partner Up to Discover, Develop and Commercialize Antibodies for Oncology and Immunology

Today, Human Genome Sciences, Inc. and Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, announced together that they have entered into a collaboration to discover, develop and commercialize therapeutic monoclonal antibodies in the fields of oncology and immunology, specifically targeting antigens discovered by HGS. “The rapid commercialization of our late-stage compounds continues to be the priority focus of HGS. At the same time, we also remain committed to advancing our earlier and mid-stage programs in development to ensure sustainable growth well into the future,” stated H. Thomas Watkins, President and Chief Executive Officer, HGS. “We look forward to…

WednesdayMar 25, 2009 5:36 am

Reed’s, Inc. (REED) Expands Relationship with Ingles Markets (IMKTA)

Reed's, Inc., maker of the top-selling sodas in natural food stores nationwide, today announced that it has expanded its relationship with Ingles Markets, Inc. (NASDAQ: IMKTA), based in Asheville, North Carolina. According to the press release, Ingles will begin taking delivery of Virgil's All Natural Sodas direct to their warehouse in North Carolina. The company will also place the products in the mainstream beverage aisle in 100 of its stores. Neal Cohane, Senior VP of Sales, National Accounts, stated, "We believe that the placement of our products in the mainstream beverage aisle will greatly enhance our brand recognition and translate…

WednesdayMar 25, 2009 5:24 am

YANGAROO Inc.’s (YOOIF.OB) DMDS 5.0 Saves Costs and Enables Green Initiative for Canada’s Juno Awards

YANGAROO Inc., a leading secure digital media distribution company, announced today that its Digital Media Distribution System (DMDS) successfully slashed costs and provided an environmentally-friendly method for distributing music and enabling the judging process for The Canadian Academy of Recording Arts and Sciences (CARAS) in association with this year’s JUNO Awards. Utilizing the technological capabilities of YANGAROO’s new DMDS 5.0 platform, more than 300 jury and 1,700 Academy members were able to review submitted materials online, eliminating the need to collect, manage and distribute approx. 15,000 physical CDs. The digital process also helped reduce costs and waste from packaging and…

WednesdayMar 25, 2009 5:18 am

IntelGenx Technologies Corp. (IGXT.OB) Reports Financial Results for 2008

IntelGenx Technologies Corp., a drug delivery company dedicated to developing oral controlled-release products as well as novel rapidly disintegrating delivery systems, this morning announced financial results for the year ended December 31, 2008. "2008 was an exciting year for IntelGenx" commented Horst Zerbe, President and Chief Executive Officer of IntelGenx. "In the fourth quarter, the first product involving the company's proprietary "Versatab" technology, a prenatal vitamin combination was launched under the brand name Gesticare®. We also formed a strategic alliance with DAVA Pharmaceuticals Inc., and completed development of the CPI-300 anti-depressant. In addition, we completed an equity financing and received…

WednesdayMar 25, 2009 5:12 am

Time to Revisit Risk

The combination of declining home values, a banking crisis, and turbulent financial markets made 2008 a year that investors won’t soon forget. In the midst of unsettled financial markets, many equity investors faced decisions about how to position their portfolios for the future. During volatile financial times, it is only natural to reconsider your own personal risk tolerance and review the role of risk in your portfolio. These guidelines can help you determine the amount of portfolio risk that is appropriate for your situation. Choose Appropriate Vehicles Many debt instruments, such as investment-grade corporate bonds, government bonds, and certain types…

TuesdayMar 24, 2009 12:09 pm

GTX Corp (GTXO.OB) Has Built a Solid Foundation for its Products

Since the industrial revolution, imaginative people have been continually creating new technology. The new devices of today often make our lives easier, but only if they work. Most international business travelers have probably faced a situation when their cellular phone or PDA does not work in a certain city or country. Companies can no longer just create electronic communication devices; they must also consider the geographic range that their products will be used. During its development phase, GTX Corp took geographic scope into account and has signed several agreements with strategic partners. GTX has a number of products ready for…

TuesdayMar 24, 2009 11:22 am

BioNeutral Group, Inc. (BONU.OB) Enters LOI to Acquire Orient Arts

BioNeutral Group, Inc., a chemical technology-based Life Science company with novel combinational chemistry, announced today that it has signed a Letter of Intent (LOI) to acquire Orient Arts Inc., a manufacturer of fibers, textiles and finished goods. BioNeutral Group plans to acquire the company through an issuance of common shares. Orient Arts and its affiliated companies are focused on manufacturing, designing and producing finished goods in Asia, the world’s largest and most populous continent. Generating collective annual sales of more than $10 million, Orient Arts and its affiliate companies have licensing agreements in place with several celebrities. Stephen J. Browand,…

TuesdayMar 24, 2009 10:54 am

Rewarding Shareholders with Dividends

Dividends, regarded as a key indicator of a company’s financial health and contributing significantly to a stock investor’s long-term wealth, can be a crucial factor in evaluating a company for long-term investment. In today’s market, it’s even more critical to build a portfolio of quality companies with the financial strength necessary to issue dividends. A recent research study found that, in the year after large-cap companies raised their dividends, they outperformed their peers (based on total return) by an average of 1.8 percentage points. Those that began paying dividends for the first time, or reinstated them after a lapse, outperformed…

Site Search

Company Search